Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial. (Q51735152)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

polycystic kidney disease

3 March 2020

main subject

1 reference

Ron T Gansevoort

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Esther Meijer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Arlene B Chapman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Frank S Czerwiec

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Olivier Devuyst

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jared J Grantham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Eiji Higashihara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Holly B Krasa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

John Ouyang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ronald D Perrone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Vicente E Torres

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

TEMPO 3:4 Investigators

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

17 December 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

Nephrology Dialysis Transplantation

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

1887-1894

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Effects of strict blood pressure control by a long-acting calcium channel blocker on brain natriuretic peptide and urinary albumin excretion rate in Japanese hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Lowering blood pressure reduces renal events in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Association of Urinary Biomarkers With Disease Severity in Patients With Autosomal Dominant Polycystic Kidney Disease: A Cross-sectional Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Early renal abnormalities in autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

A comparative study of three kidney biomarker tests in autosomal-dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Potential Deleterious Effects of Vasopressin in Chronic Kidney Disease and Particularly Autosomal Dominant Polycystic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFV422

Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study

21 January 2018

1 reference

12 December 2020

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

12 December 2020

Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease

1 reference

12 December 2020

Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.

1 reference

12 December 2020

Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDT/GFV422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

PubMed publication ID

26681730

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26681730%20AND%20SRC:MED&resulttype=core&format=json